▲ Peaking
Health
New weight-loss drug wipes out chronic knee pain in some patients, researchers say
Weight-loss drugs significantly ease chronic knee arthritis pain in major trials, according to health coverage.
3 trends tracked about this subject — the full history, oldest to newest below.
Weight-loss drugs significantly ease chronic knee arthritis pain in major trials, according to health coverage.
Eli Lilly's Zepbound shows promise for knee pain relief alongside weight loss in new Phase 3b data, while Taltz combination therapy demonstrates durable psoriatic arthritis outcomes.
MoonLake Immunotherapeutics reports that its nanobody drug, sonelokimab, successfully met all clinical endpoints in a Phase 3 trial for psoriatic arthritis.